Inside Health

• HPV vaccination has significantly reduced cervical cancer incidence in vaccinated cohorts, prompting reconsideration of screening frequency and intensity in this population
• Cervical screening programmes may be able to reduce screening intervals or transition to risk-stratified approaches in highly vaccinated populations, though complete cessation is not recommended
• Clinical decisions on screening modifications should be based on individual HPV vaccination status, age, and local epidemiological data rather than blanket policy changes

Does the success of the HPV vaccine mean that cervical screening can be reduced?

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.